Free Trial Information
BioCentury | Jan 15, 2015
Finance

Consortia cross-talk

...2013 Universal Influenza Vaccines Secured (UNISEC) consortium BiondVax Pharmaceuticals Ltd. (Tel Aviv:BNDX); Isconova AB (SSE:ISCO); Retroscreen Virology Group plc...
Read More
BioCentury | Aug 18, 2014
Financial News

Retroscreen Virology completes placing

Retroscreen Virology Group plc (LSE:RVG), London, U.K. Business: Supply/Service Date completed: 2014-08-14 Type: Placing Raised: L33.6 million ($56.4 million) Shares: 12.9 million Price: 260p Shares after offering: 67.6 million Placement agent: Numis Securities Investors: New...
Read More
BioCentury | Aug 18, 2014
Finance

Highlights of weekly biotech stock moves

...AuriPro ciprofloxacin to treat middle ear effusion in pediatric patients requiring tympanostomy tube placement surgery. Retroscreen Virology Group plc...
Read More
BioCentury | Aug 15, 2014
Financial News

Retroscreen raises L33.6 million

Retroscreen Virology Group plc (LSE:RVG) raised L33.6 million ($56.4 million) through the sale of 12.9 million shares at 260p in a placing with existing and new institutional investors. The price is a 19% discount to...
Read More
BioCentury | Oct 21, 2013
Company News

BiondVax, Isconova, Retroscreen Virology, Seek Ltd., Medicines and Healthcare products Regulatory Agency (MHRA), National Center for Epidemiology, Norwegian Ins

...influenza virus. BiondVax Pharmaceuticals Ltd. (Tel Aviv:BNDX), Ness Ziona, Israel Isconova AB (SSE:ISCO), Uppsala, Sweden Retroscreen Virology Group plc...
Read More
BioCentury | Jun 17, 2013
Finance

Highlights of weekly biotech stock moves

...analyst raised his price target for Questcor following the deal (see Analyst Picks, A22) . Retroscreen Virology Group plc...
Read More
BioCentury | Jun 17, 2013
Financial News

Retroscreen Virology completes placing

Retroscreen Virology Group plc (LSE:RVG), London, U.K. Business: Supply/Service Date completed: 6/14/13 Type: Placing Raised: £25.5 million ($39.6 million) Shares: 12.8 million Price: 200p Shares after offering: 53.7 million Placement agent: Numis Securities Investors: New...
Read More
BioCentury | Jun 15, 2013
Financial News

Retroscreen raises L25.5 million

Retroscreen Virology Group plc (LSE:RVG) raised L25.5 million ($39.6 million) through the sale of 12.8 million shares at 200p in a placing with existing and new institutional investors. The price is a 29% discount to...
Read More
BioCentury | Jan 14, 2013
Finance

Darwin's delight

...Inc. (NASDAQ:DRTX) 7/19/12 $77.6 $165.3 $140.4 -15% Tesaro Inc. (NASDAQ:TSRO) 6/27/12 $86.8 $365.9 $459.8 26% Retroscreen Virology Group plc...
Read More
BioCentury | Jan 14, 2013
Company News

Retroscreen Virology, Centers for Disease Control and Prevention infectious news

...from the study at the end of this year. The company declined to disclose details. Retroscreen Virology Group plc...
Read More
Items per page:
1 - 10 of 14
BioCentury | Jan 15, 2015
Finance

Consortia cross-talk

...2013 Universal Influenza Vaccines Secured (UNISEC) consortium BiondVax Pharmaceuticals Ltd. (Tel Aviv:BNDX); Isconova AB (SSE:ISCO); Retroscreen Virology Group plc...
Read More
BioCentury | Aug 18, 2014
Financial News

Retroscreen Virology completes placing

Retroscreen Virology Group plc (LSE:RVG), London, U.K. Business: Supply/Service Date completed: 2014-08-14 Type: Placing Raised: L33.6 million ($56.4 million) Shares: 12.9 million Price: 260p Shares after offering: 67.6 million Placement agent: Numis Securities Investors: New...
Read More
BioCentury | Aug 18, 2014
Finance

Highlights of weekly biotech stock moves

...AuriPro ciprofloxacin to treat middle ear effusion in pediatric patients requiring tympanostomy tube placement surgery. Retroscreen Virology Group plc...
Read More
BioCentury | Aug 15, 2014
Financial News

Retroscreen raises L33.6 million

Retroscreen Virology Group plc (LSE:RVG) raised L33.6 million ($56.4 million) through the sale of 12.9 million shares at 260p in a placing with existing and new institutional investors. The price is a 19% discount to...
Read More
BioCentury | Oct 21, 2013
Company News

BiondVax, Isconova, Retroscreen Virology, Seek Ltd., Medicines and Healthcare products Regulatory Agency (MHRA), National Center for Epidemiology, Norwegian Ins

...influenza virus. BiondVax Pharmaceuticals Ltd. (Tel Aviv:BNDX), Ness Ziona, Israel Isconova AB (SSE:ISCO), Uppsala, Sweden Retroscreen Virology Group plc...
Read More
BioCentury | Jun 17, 2013
Finance

Highlights of weekly biotech stock moves

...analyst raised his price target for Questcor following the deal (see Analyst Picks, A22) . Retroscreen Virology Group plc...
Read More
BioCentury | Jun 17, 2013
Financial News

Retroscreen Virology completes placing

Retroscreen Virology Group plc (LSE:RVG), London, U.K. Business: Supply/Service Date completed: 6/14/13 Type: Placing Raised: £25.5 million ($39.6 million) Shares: 12.8 million Price: 200p Shares after offering: 53.7 million Placement agent: Numis Securities Investors: New...
Read More
BioCentury | Jun 15, 2013
Financial News

Retroscreen raises L25.5 million

Retroscreen Virology Group plc (LSE:RVG) raised L25.5 million ($39.6 million) through the sale of 12.8 million shares at 200p in a placing with existing and new institutional investors. The price is a 29% discount to...
Read More
BioCentury | Jan 14, 2013
Finance

Darwin's delight

...Inc. (NASDAQ:DRTX) 7/19/12 $77.6 $165.3 $140.4 -15% Tesaro Inc. (NASDAQ:TSRO) 6/27/12 $86.8 $365.9 $459.8 26% Retroscreen Virology Group plc...
Read More
BioCentury | Jan 14, 2013
Company News

Retroscreen Virology, Centers for Disease Control and Prevention infectious news

...from the study at the end of this year. The company declined to disclose details. Retroscreen Virology Group plc...
Read More
Items per page:
1 - 10 of 14